返回
Alps Group Inc（GLLIR）價格
GLLIR 股價走勢圖
GLLIR 收益
Alps Group Inc
$0.26
13.04%
$0.03
收盤價：Jan 20, 16:00:00 GMT-5
$0.26
0%
$0
盤後：Jan 20, 20:00:00 GMT-5
關鍵數據
前收市價
$0.23
開盤價
$0.221
當日範圍
$0.22 - $0.28
52週區間
$0.22 - $0.28
交易量
120.4K
平均成交量
415.6K
每股盈餘 (TTM)
-0.51
股息收益率
--
市值
$43.2M
什麼是 GLLIR？
Alps Group Inc is a MY-based company operating in Biotechnology industry. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2025-10-31. Alps Group Inc is the parent company of Alps Life Sciences Inc., an integrated biotechnology platform integrating research and development, medical services, and wellness solutions of advanced therapies under one unified ecosystem aimed at improving healthcare outcomes globally. The firm has cultivated a diverse pipeline covering various biotechnology research areas. This includes initiatives focused on MyImmune (NK cells), CAR-T cells, COVID-19 mRNA vaccine, diabetes therapeutics, and advancements in stem cell technologies such as induced Pluripotent Stem Cells (iPSCs) and messenger ribonucleic acid (mRNA) platform technology. The firm provides aesthetic treatments, cosmetic procedures, general healthcare and wellness services. The Company’s aesthetic services and cosmetic surgery services include non-surgical aesthetic services and surgical aesthetic services. The company operates a molecular laboratory and a cGMP cell and gene therapy research and cultivation laboratory.